Company profile for Pharmadrug Production GmbH

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in 1982, Pharmadrug today is ranked among the leading export-orientated pharmaceutical companies in Germany. The product portfolio includes the domains of manufacturing and distribution of medicinal products and marketing of healthcare products and pharmaceutical substances. The manufacturing of our high-quality generic medicinal products is performed in compliance with the EU-cGMP guidelines. The high-capacity, st...
Established in 1982, Pharmadrug today is ranked among the leading export-orientated pharmaceutical companies in Germany. The product portfolio includes the domains of manufacturing and distribution of medicinal products and marketing of healthcare products and pharmaceutical substances. The manufacturing of our high-quality generic medicinal products is performed in compliance with the EU-cGMP guidelines. The high-capacity, state-of-the-art production, the qualified staff, the range of preparations, covering important therapeutic fields, as well as the international focusing are the pillars, distinguishing Pharmadrug to be a reliable and customer-orientated partner for the worldwide health care market.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Saseler Chaussee 191a 22393 Hamburg
Telephone
Telephone
+49 (0)40 28 80 58 18-0
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.biospace.com/article/pharmadrug-initiates-preclinical-study-of-cepharanthine-to-both-broaden-its-cancer-scope-and-to-streamline-its-strategy-for-esophageal-cancer/

BIOSPACE
06 May 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty